SUMMARY Many patients with hypertrophic cardiomyopathy die suddenly and unexpectedly, a significant number perhaps due to arrhythmia. Of 100 patients initially evaluated for signs or symptoms suggestive of heart disease or a family history of hypertrophic cardiomyopathy, 51 were selected solely because they met the echocardiographic criteria for the disease, and 49 patients were selected primarily because they had: 1) normal sinus rhythm despite left atrial enlargement, 2) a history of syncope, 3) a family history of premature death, or 4) a history of paroxysmal atrial fibrillation. All 100 patients were studied by 24-hour ambulatory electrocardiographic monitoring and 74 of them also underwent treadmill exercise testing. More than 50% of patients in all subgroups (with or without symptoms or left ventricular outflow tract obstruction) had multiform or repetitive ventricular premature depolarizations, including 19% who had ventricular tachycardia. Monitoring was superior to exercise testing for exposing these arrhythmias. Two patients experienced cardiac arrest within 2 months of monitoring; in each, monitoring had revealed ventricular tachycardia. Two patients with paroxysms of supraventricular tachycardia during monitoring developed fixed atrial fibrillation within 1 year. These preliminary observations suggest that monitoring may help identify patients at increased risk for significant arrhythmic events.
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MANY SYMPTOMATIC PATIENTS with hypertrophic cardiomyopathy die suddenly and unexpectedly during the course of their disease.'`' We have identified several people with hypertrophic cardiomyopathy in whom sudden death was the initial manifestation of disease. 5 Despite the clinical importance of this problem and the likelihood that many of these sudden deaths are arrhythmic in origin,6 surprisingly little is known about the propensity of patients with hypertrophic cardiomyopathy to develop arrhythmias.
In the present investigation we used 24-hour ambulatory electrocardiographic monitoring and treadmill exercise testing to examine the frequency and types of arrhythmias that occur in a large population of patients with hypertrophic cardiomyopathy. We sought to determine whether subgroups of patients with this disease are particularly susceptible to the development of arrhythmias. We also compared the sensitivity of 24-hour ambulatory electrocardiographic monitoring with that of treadmill exercise testing in detecting arrhythmias. Finally, we made a preliminary attempt to determine whether any electrocardiographic findings were predictive of subsequent mortality.
One hundred patients with hypertrophic cardiomyopathy (asymmetric septal hypertrophy (ASH)) were studied after informed consent was secured. ASH was defined echocardiographically by a ventricular septal-to-posterobasal left ventricular freewall thickness ratio 1.3.7 Seventy-six of the patients were male and 24 were female. Initial signs or symptoms of cardiac disease in the 100 patients were detected an average of 14 ± 1 years (SEM) before electrocardiographic monitoring. These included: heart murmurs detected in then asymptomatic patients during physical examinations in 55%; chest pain or dyspnea on exertion in 18%; lightheadedness or syncope in 7%; palpitations in 2%; left ventricular enlargement on routine chest x-ray in 1%; increased QRS voltage, ST-T changes or abnormal Q waves on routine ECGs in 4%; and diagnostic echocardiograms performed during family screening studies in 13%. Fifty-one patients were entered into the study solely because ASH had been identified by echocardiography and they were being followed in our clinic. The other 49 patients were selected from our large clinic population, mainly to provide a cross-section of the several clinical and hemodynamic subgroups of patients with this disease. Of these 49 patients 17 were selected because they had normal sinus rhythm despite a large left atrial dimension on echocardiogram; 16 were studied primarily because of a history of syncope; eight came from families in which premature death (i.e., <50 years of age) had occurred in two or more first-degree relatives who had hypertrophic cardiomyopathy ("'malignant" families"); and eight were selected because of their history of paroxysmal atrial ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY/Savage et al.
fibrillation. One of the latter eight patients also had a history of syncope. In addition, one of the patients from a "malignant" family also had a history of paroxysmal atrial fibrillation and three other patients from such families had a history of syncope. Included in the group of 100 patients were three who had known fixed atrial fibrillation, two who had known sinus arrest (or slowing) with junctional escape beats, and two with premature depolarizations on routine 12-lead ECG (one with an isolated supraventricular premature (SPD) and one with an isolated ventricular premature depolarization (VPD) ). No other patients in the study had known arrhythmias documented either clinically or by routine 12-lead ECG.
Sixty-one of the 100 patients underwent cardiac catheterization as soon as 1 day after, but up to 14 years (median 4 years) before electrocardiographic monitoring. In 26 of these patients the catheterization was within 2.5 years of the monitoring. In these latter patients the resulting hemodynamic data were used to determine the presence or absence of obstruction. Patients were considered to have obstruction if the gradient measured under basal conditions or with provocation (i.e., isoproterenol infusion or Valsalva maneuver) was .30 mm Hg. Those with smaller gradients or no gradient were considered not to have obstruction.
At the National Institutes of Health, routine diagnostic catheterization is no longer performed in patients in whom the disease has been diagnosed by echocardiography. Nor did we believe it was ethically justified to recatheterize patients who had undergone catheterization several years before this investigation. Hence, to include a meaningful number of study patients, we relied on echocardiographic identification of systolic anterior motion (SAM) of the anterior mitral leaflet to confirm the hemodynamic results in those patients in whom cardiac catheterization was carried out more than 2.5 years before monitoring, and to include an additional 33 patients in the study who were not catheterized, but in whom the mitral valve could be adequately recorded by echocardiography to determine the presence or absence of SAM. The magnitude of obstruction was estimated by previously described echocardiographic methods based on the degree of approximation of the anterior mitral leaflet to the ventricular septum.3 9 Mean age of the patients with and without obstruction was the same (38 + 2 years (SEM), ranges 9-65 and 12-64 years, respectively). None of the patients had undergone cardiac operation before electrocardiographic monitoring. However, 13 of the 42 symptomatic patients with obstruction were considered symptomatic enough to undergo septal myotomy and myectomy 2 weeks to 12 months after study.
Monitoring Procedure
We obtained continuous 24-hour electrocardiographic recordings using a portable cassette tape recorder and a modified V5 lead either with or without a simultaneous modified V, lead. Cardioactive medications were discontinued 24-48 hours before monitoring, with the exception of one patient who had chronic atrial fibrillation and continued to take digoxin. In patients taking propranolol, the drug was gradually discontinued during 3-4 days before monitoring. Three patients had antiarrhythmic medications reinstituted after 2-5 hours of monitoring because they had paroxysmal ventricular tachycardia or atrial fibrillation detected by simultaneous telemetry. Sixty-eight of the patients were monitored outside of the hospital. The remaining 32 were monitored during a hospital admission. All, however, were ambulatory and encouraged to be active.
Analysis of the 24-hour continuous electrocardiographic records was aided by the use of a highspeed digital computer system (Clinical Data, Inc, Boston, Massachusetts). This system permits the stationary visual display of 2 minutes of electrocardiographic data on a cathode ray tube screen. The electrocardiographic data is held on the screen for as long as necessary to identify arrhythmic sequences and validate frequency of ectopic events and any part of the display may be printed for hard copy examination. The playback system also permits the generation of mean heart rate for each minute of a recording and the quantitation by morphology of ectopic activity. Representative electrocardiographic tracings during arrhythmias, significant patient activities or symptoms recorded by the patient in his or her log were recorded for independent assessment and verification.
Premature depolarizations and arrhythmias were identified and graded by each of two investigators. The ventricular arrhythmia grading system used was similar to the system of Lown et al. ' Thirty-two patients with and 42 patients without obstruction to left ventricular outflow underwent treadmill exercise testing. Exercise tests and the routine 12-lead ECGs were performed within 1 week of 24-hour electrocardiographic monitoring in all but two patients, in whom electrocardiographic monitoring was performed 7 months after exercise testing. All medications were discontinued before the study as described in the monitoring procedure. Electrocardiographic leads were arranged with a reference electrode over the manubrium and exploring electrodes in the V5 position and over the lumbar spine. The We performed echocardiographic studies with an Aerotech transducer (2.25 MHz, 1.25-cm diameter, unfocused) and a modified Ekoline 20A or a Hoffrel 201 ultrasound unit using methods previously described.7 The ultrasound signal was connected via a custom-built video amplifier to a Honeywell 1856 Visicorder and recorded continuously on lightsensitive paper. The thickness of the ventricular septum was measured below the tips of the mitral valve leaflets before atrial systole but after rapid ventricular filling. Posterobasal left ventricular free-wall thickness was measured at the level of the tips of the mitral valve leaflets during the same phase of the cardiac cycle. Left atrial transverse dimension was taken as the maximal distance between the posterior aortic wall and the posterior left atrial wall and measured in the damped portion of the record when the ultrasonic beam passed through the aortic leaflets.' members of "malignant" families was similar to that of patients not from such families. In addition, the frequency of high grade ventricular arrhythmias in the 51 patients studied solely because they had ASH was similar to that of the 49 patients selected because they were in specific subgroups.
Nine patients had more than one episode of ventricular tachycardia, including two patients who, within 2 months of ambulatory monitoring, had a cardiac arrest and were subsequently found to be in ventricular fibrillation. Although one of these patients (TB) was resuscitated, he experienced permanent anoxic cerebral damage. The second patient (DR) could not be resuscitated and died several hours after her initial arrest. Each patient also had multiform and paired VPDs on 24-hour tapes. At the time of cardiac arrest, both patients were taking propranolol (160 mg/day) and one was also taking quinidine (1200 mg/day). Three weeks before the latter patient's death, her quinidine blood level had been in the therapeutic range (5.7 mg/l). Supraventricular A rrhythmias Fifty-four of the 100 patients had SPDs recorded on the 24-hour ECG. The total number of SPDs ranged from 1-13,325 beats in 24 hours ( fig. 5 ). Only 11 patients had >100 SPDs and three had >500 SPDs in 24 hours. All patients with more frequent SPDs (> 100 SPDs in 24 hours) had an echocardiographic left atrial dimension >40 mm ( fig. 5) . However, the converse was not true. Thus, 56 of 67 patients (84%) with left atrial dimension >40 mm had infrequent SPDs. Although patients with left ventricular outflow obstruction were more likely to have SPDs than patients without obstruction, all subgroups had similar percentages of patients with more frequent SPDs (table 3) .
Fifteen patients had paroxysms of supraventricular tachycardia during the monitoring. Two of the 15 also had paroxysmal atrial fibrillation on the 24-hour ECG. Seven of these 15 had a previous history of paroxysmal atrial fibrillation and six of the remaining eight had a history of palpitations suggestive of arrhythmia. As with VPDs, there was an excellent correlation between maximum SPDs/hour with total SPDs/24 hours (r = 0.998,p < 0.001). There was no significant correlation between frequency of SPDs and frequency of VPDs.
Two patients developed fixed atrial fibrillation 7 and 12 months, respectively, after the monitoring, during which each had had paroxysms of supraventricular tachycardia.
Effect ofSleep on Arrhythmias
Arrhythmias during sleep were not uncommon. We detected no significant difference in total VPDs or SPDs/hour in the total patient population during hours awake compared with hours asleep. Seven tOnly two of the 24 hours of monitoring off medications. §A11 patients with VT also had multifocal and/or paired VPDs except these three patients. ¶This patient also had 708 runs of accelerated idioventricular rhythm at rates of 50-60 beats/min.
Abbreviation: VT = ventricular tachycardia.
The 12-lead resting ECG detected only two patients with arrhythmias (one with an isolated SPD and one with an isolated VPD). The poor sensitivity of the 12-lead ECG compared with 24-hour electrocardiographic monitoring and exercise testing is obvious and will not be considered further.
The frequencies with which ventricular arrhythmias were exposed by ambulatory electrocardiographic monitoring and treadmill exercise testing are summarized in table 6. Only the 74 patients who had both exercise testing and 24-hour electrocardiographic monitoring are included in this analysis. VPDs were detected on one of the two tests in 62 of 74 patients (84%). Forty-five of 62 patients (73%) with VPDs were detected by exercise testing while 61 of 62 (98%) were detected by 24-hour electrocardiographic monitoring.
During 24-hour monitoring, 49 patients had VPD grade 3 or higher. Only 21 of these 49 patients had VPD grade 3 or higher during exercise. Even an exercise test that provoked no arrhythmia whatsoever was no assurance that high grade ventricular arrhythmias would not be detected by 24-hour monitoring. Conversely, every patient who had VPD grade 3 or higher on exercise testing also had high grade VPDs detected by 24-hour monitoring. Finally, 11 of 15 patients had ventricular tachycardia detected exclusively by 24-hour electrocardiographic monitoring. One patient had ventricular tachycardia exclusively during exercise.
One of the two patients who had a sudden cardiac arrest during follow-up (vide supra) had a brief episode of ventricular tachycardia immediately after CIRCULATION Other preliminary studies have also reported that high grade ventricular arrhythmias occur frequently in patients with hypertrophic cardiomyopathy.'2 '3 Obviously, the significance of such a finding depends in part on the frequency of these arrhythmias in normal subjects. Unfortunately, definitive data from normal subjects are lacking, although the studies performed in subjects with apparently normal hearts have shown that the frequency of high grade ventricular arrhythmias is probably less than 15%."4-16 Hence, these data suggest that hypertrophic cardiomyopathy is probably causally rather than coincidentally related to the arrhythmias.
Even asymptomatic patients without left ventricular outflow obstruction had a prevalence of high-grade arrhythmias exceeding 50%. In fact, three of 11 asymptomatic patients without obstruction, but with high-grade arrhythmias, had ventricular septal-to-left 874 CIRCULATION data suggest that monitoring during a complete diurnal cycle markedly increases the sensitivity for arrhythmia detection. As in studies of other types of patients,'0 20 the present investigation indicates that 24-hour ambulatory electrocardiographic monitoring is superior to exercise testing for detecting arrhythmias in patients with hypertrophic cardiomyopathy. In particular, 57% of patients who had high VPD grade (. grade 3) on 24-hour monitoring had low grade or no VPDs on exercise testing. In contrast, all patients who had high VPD grade on exercise testing also had high VPD grade on 24-hour monitoring.
Despite our preliminary follow-up data, the precise prognostic relation of the various types of arrhythmias detected by ambulatory monitoring to subsequent morbid events, such as cardiac arrest and atrial fibrillation, is uncertain. However, 24-hour electrocardiographic monitoring documents a high prevalence of potentially serious arrhythmias in patients with hypertrophic cardiomyopathy. Detection of such arrhythmias may help identify patients who are at increased risk for subsequent morbid events. 
